Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of quercetin in preparation of prostate cancer radiotherapy sensitizing drug

A technology for prostate cancer and quercetin, which is applied in the field of medicine to increase the DNA damage of tumor cells, has wide application prospects and improves the sensitivity of radiotherapy

Inactive Publication Date: 2021-04-16
CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There is no relevant report on the application of quercetin in radiosensitization of prostate cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of quercetin in preparation of prostate cancer radiotherapy sensitizing drug
  • Application of quercetin in preparation of prostate cancer radiotherapy sensitizing drug
  • Application of quercetin in preparation of prostate cancer radiotherapy sensitizing drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1, quercetin is administered to prostate cancer cell

[0030] 1. Effect of quercetin on radiosensitivity of prostate cancer cells

[0031] 1.1 The following prostate cancer cells are prostate cancer 22Rv1 cells:

[0032] Prostate cancer 22Rv1 cells (cells express both AR and ARv7 proteins, hereinafter also referred to as 22Rv1 cells), Cell Resource Center, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, catalog number SCSP-5022;

[0033] 1.2. Divide the prostate cancer cells into the following groups and use them separately:

[0034] Quercetin treatment group (IR+Que group): Prostate cancer cells were cultured in 1640 medium containing 40 μmol / L quercetin for 24 hours to obtain prostate cancer cells treated with quercetin alone, and treated with 2Gy, 4Gy and 6Gy respectively X-rays (Tumor Hospital, Chinese Academy of Medical Sciences) were irradiated, and after irradiation, new cell culture medium (there was no quercetin in the new...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel pharmaceutical application of quercetin. The new application is the application of quercetin in preparation of cancer radiotherapy sensitizing drugs. The application of quercetin in preparation of a radiotherapy sensitizer is provided for the first time, and the quercetin can effectively improve the radiotherapy sensitivity of tumor cells and improve the radiotherapy curative effect. The action mechanism of the quercetin is related to the capability of the quercetin in inhibiting androgen receptor (AR) and AR splicing variant 7 (ARv7) activating signal paths and increasing tumor cell DNA damage, and the quercetin has a wide application prospect.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of quercetin in the preparation of prostate cancer radiotherapy sensitization drugs. Background technique [0002] Prostate cancer is one of the common malignant tumors in men. According to the latest cancer statistics, it is estimated that there will be about 1.2761 million new prostate cancer patients in the world in 2018, accounting for 13.5% of male cancers. It is the second most common male malignant tumor after lung cancer. In my country, with the aging of the population structure, the improvement of people's living standards and the change of diet structure, the incidence of prostate cancer presents a rapid upward trend, and the incidence tends to be younger. [0003] At present, surgery, radiation therapy and endocrine therapy are the three "sharp weapons" for the treatment of prostate cancer. For patients with early localized prostate cancer, surgery or radia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P35/00A61N5/10
Inventor 邢念增陈东杨飞亚
Owner CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com